Life Sciences Excellence Initiative
A Talbot West research initiative investigating how life sciences enterprises become more intelligent, capable, and economically successful.
We apply our Theory of Enterprise Coherence to how companies perceive, understand, act upon, and learn from reality, and to the economic possibilities that follow when those capabilities improve.
Explore the research cohort ↗A company thinks and acts through a distributed apparatus of people, expertise, information, technology, processes, incentives, and authority. No single leader, department, database, or AI system contains its intelligence.
That arrangement is capable of remarkable accomplishments. It also creates opportunities for things to go wrong. Evidence fails to reach the people who need it. Legitimate local judgments remain disconnected. Sound insights never change consequential decisions. Capable teams do intelligent things, yet the enterprise behaves incoherently.
Talbot West's Theory of Enterprise Coherence investigates this phenomenon: how the parts of an enterprise combine to produce its understanding, decisions, and behavior, and how well that behavior fits the reality that matters.
Small cognitive failures can produce enormous economic consequences. Small cognitive improvements can produce enormous economic benefits.
In life sciences, consequential decisions span research, products, quality, regulation, manufacturing, supply networks, commercialization, and the people responsible for coordinating them. The difficulty is not always a lack of expertise. It is how the enterprise combines knowledge and turns it into effective action.
AI substantially increases what individual functions and teams can accomplish. Whether that added power improves enterprise outcomes depends on the surrounding system of judgment, information, authority, and action.
The opportunity extends beyond correcting mistakes. More capable enterprise cognition may expose possibilities that existing arrangements have made difficult to recognize or realize.
LSEI explores how life sciences companies encounter and navigate reality, how collective intelligence develops or breaks down, and what becomes possible when enterprises operate more coherently.
Among the questions worth investigating:
How do important signals become visible, intelligible, and consequential across organizational boundaries?
Where does valuable expertise remain isolated from decisions and actions that depend on it?
How do companies revise their understanding when the evidence challenges established assumptions?
How might combinations of people, organizational arrangements, data, technology, and AI produce substantially greater capability or economic value?
What new opportunities emerge when a company sees its possibilities more clearly, including beyond its own organizational boundaries?
These are directions for inquiry, not a fixed menu of diagnostic services. Real company situations, expert contributions, and emerging findings shape the research.
The research draws on company-specific investigations, executive conversations, independent analysis, comparative findings, and contributions from people with substantial domain expertise.
A company may bring an important question or ambition. Researchers and specialists may contribute knowledge of manufacturing, quality, regulation, organizational systems, AI, capital, or related fields. Connections across these perspectives may expose opportunities none of the participants would recognize alone.
LSEI's research cohort is one concrete way companies participate. Other intellectual collaborations and initiatives may develop as worthwhile questions and people come together.
The executive research cohort offers a structured opportunity to examine a consequential company-specific question, receive a confidential executive briefing and comparative intelligence, exchange perspectives with peers, and help shape the wider inquiry.
Participation is selective and carries no fee. Full details, format, and the invitation appear on the cohort page.
Explore the executive research cohort ↗We welcome conversations with people who have important questions, distinctive expertise, and an interest in original research or consequential collaboration. Intellectual contributions, relevant introductions, specialized investigations, and broader opportunities can take different forms.
Discuss collaboration with Jacob Andra ↗Talbot West works across strategy, engineering, operations, organizational systems, data, and AI. Its original Theory of Enterprise Coherence provides an intellectual foundation for examining how intelligent parts of an enterprise combine into effective, or ineffective, collective behavior.
BioUtah's Utah Life Sciences Summit
November 11, 2026 · Salt Lake City
Jacob Andra, Founder and CEO, Talbot West
The presentation examines why capable people and sophisticated AI may still produce unintelligent enterprise behavior. LSEI pursues the accompanying question: how might enterprises become exceptionally capable?
